Standard Biotools | FLDM - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agilent USD 1.44B 9M 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Danaher USD 52.95B 47.61B 2026-03
Illumina USD 852M 51M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
Nikon Corporation JPY 202.07B 67.73B 2026-03
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Revvity USD 628.34M 2.12M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sony JPY 2.81T 396.47B 2026-03
Standard Biotools USD 30.56M 15.16M 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Waters USD 1.12B 457.15M 2026-03